Serum Messenger RNA as a Biomarker and its Clinical Usefulness in Malignancies
A number of biomarkers are used clinically and many protein-based assay methods are available. Improvements in the method to utilize specific antibodies have led to remarkable progress in clinical diagnosis using biomarkers. Proteomics studies to identify better biomarkers have been performed worldw...
Main Authors: | Norimasa Miura, Junichi Hasegawa, Goshi Shiota |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-01-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.4137/CMO.S379 |
Similar Items
-
Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study
by: Oshima Yoshiaki, et al.
Published: (2010-10-01) -
A novel biomarker TERTmRNA is applicable for early detection of hepatoma
by: Hirooka Yasuaki, et al.
Published: (2010-05-01) -
1377 Messenger RNA nanoparticles targeting fusion-driven malignancies
by: Leighton Elliott, et al.
Published: (2023-11-01) -
Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma
by: Timothy Block, et al.
Published: (2022-12-01) -
Matrices Activated with Messenger RNA
by: Raquel Martinez-Campelo, et al.
Published: (2023-01-01)